Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Olaszország
34 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Where
- Ancona, Brescia, Candiolo, Milan, Monza, Novara, Palermo, Ravenna, Rionero In Vulture, Rome
- Életkor
- 18 év and over
- People
- 1046 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00 - 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Brescia, Meldola, Milan, Naples, Rozzano
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 3. fázisTaking peopleA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Where
- Meldola, Milan, Modena, Monza, Naples, Novara, Pavia, Perugia, Ravenna, Roma, Turin, Udine, Varese
- Életkor
- 18 év and over
- People
- 904 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00 - 1. fázisTaking peopleA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Bologna, Milan
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 2/3. fázisTaking peopleA Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Where
- Naples, Rozzano
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00 - 1. fázisTaking peopleIKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
- Where
- Candiolo, Milan
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659 - 2. fázisTaking peopleA Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Where
- Alexandria, Brescia, Meldola, Milan, Naples, Palermo, Reggio Emilia, Rozzano
- Életkor
- 18 év and over
- People
- 594 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06890884 · EU 2024-515526-89-00 - 1. fázisNot yet taking people in OlaszországStudy to Evaluate the Feasibility and Safety of Autologous Cytokine-Induced Killer Cells (CIK_D332) in Combination With Tafasitamab and Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Where
- Padova, Verona
- Életkor
- 18 év to 99 év
- People
- 14
- Run by
- Istituto Oncologico Veneto IRCCS
See details and how to joinNCT07906080 · EU 2026-525494-39-00 - 1. fázisTaking peopleA Study of ARC-02 in B-cell NHL
- Where
- Aviano, Bergamo, Bologna, Rozzano
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Milan, Rome, Turin
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 1. fázisTaking peopleA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- Where
- Bologna, Milan, Rome, Verona
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07195916 · EU 2025-523130-11-00 - 1/2. fázisTaking peopleA Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Where
- Bologna, Milan, Roma, Verona
- Életkor
- 18 év and over
- People
- 689 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT05006716 · EU 2022-502157-33-00 - No phaseTaking peopleLifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors
- Where
- Ancona, Aviano, Bari, Barletta, Belluno, Bolzano, Brescia, Brindisi, Caltanissetta, Catania, Como, Florence, Lecce, Legnano, Messina, Milan, Modena, Novara, Padova, Pagani, Palermo, Pescara, Piacenza, Pisa, Potenza, Reggio Emilia, Rimini, Roma, Rozzano, Sassari, Sassuolo, Torino, Treviso
- Életkor
- 18 év to 50 év
- People
- 552
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT05934084 - 1/2. fázisTaking peopleA Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Where
- Bologna, Milan, Rome, Rozzano
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04104776 · EU 2023-508002-20-00 - 2. fázisTaking peopleCombining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
- Where
- Bologna, Milan, Naples
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Universität Münster
See details and how to joinNCT07197307 · EU 2023-509861-19-01 - 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Bologna, Brescia, Milan, Rome
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - No phaseNot yet taking people in OlaszországCharacterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) by Multiomic Approach
- Where
- Pavia
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- International Extranodal Lymphoma Study Group (IELSG)
See details and how to joinNCT07147751 - No phaseNot yet taking people in OlaszországNeurocognitive Assessment in Long-Term Survivors of Lymphoma
- Where
- Ancona, Aviano, Bari, Legnano, Milan, Palermo
- Életkor
- 25 év to 55 év
- People
- 100
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07652476 - 2. fázisTaking peopleEfficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
- Where
- Turin
- Életkor
- 18 év to 70 év
- People
- 213 worldwide
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT04844866 · EU 2023-506270-13-00 - No phaseTaking peopleMulticenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma
- Where
- Reggio Emilia
- Életkor
- 18 év and over
- People
- 50
- Run by
- Azienda USL Reggio Emilia - IRCCS
See details and how to joinNCT06822829 - No phaseTaking peopleBio-CAR-T BS Study
- Where
- Brescia
- Életkor
- 18 év to 70 év
- People
- 45
- Run by
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
See details and how to joinNCT05366569 - No phaseNot yet taking people in OlaszországGeriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment
- Where
- Ancona, Avellino, Aviano, Bari, Brescia, Cagliari, Florence, Milan, Monza, Padova, Palermo, Parma, Piacenza, Prato, Ravenna, Reggio Emilia, Roma, Siena, Teramo, Torino, Udine, Verona
- Életkor
- 70 év and over
- People
- 170
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07476105 - No phaseNot yet taking people in OlaszországNeurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy
- Where
- Alessandria, Ancona, Brescia, Palermo, Reggio Calabria, Roma, Taranto, Udine
- Életkor
- 18 év and over
- People
- 100
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT07463781 - No phaseTaking peopleReal-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
- Where
- Bari, Milan, Naples, Palermo, Rome, Turin
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- AbbVie
See details and how to joinNCT06830759 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Alexandria, Milan, Turin, Verona
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00